You searched for "oedema"
Licence to save: a UK survey of anti-VEGF use for the eye
1 February 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
Strategies for managing neovascular AMD and DMO in routine clinical care
1 October 2015
| Rod McNeil
|
EYE - Vitreo-Retinal
Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...
Moorfields implementing a non-medical intravitreal injection service
28 March 2025
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...
Anterior capsular tears complicating phacoemulsification surgery
This is a retrospective, interventional case series, assessing the occurrence of anterior capsular tears in phacoemulsification surgery, its effect on outcomes and further complications. Despite being a well recognised complication of phacoemulsification surgery the authors felt that there is a...Moorfields: Implementing a non-medical intravitreal injection service
4 July 2025
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...
Type 3 macular neovascularisation (MNV) due to age-related macular degeneration
3 October 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This paper systematically reviews and summarises the current knowledge on type 3 neovascularisation due to age-related macular degeneration which is defined as neovascularisation originating from the retinal deep capillary plexus that grows towards the outer retina often penetrating the level...
Ocular complications in retinal vasculitis
1 February 2018
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
In this retrospective study the authors aimed to characterise the incidence rates of visual loss and ocular complications associated with retinal vasculitis (RV – annual incidence of 1-2/ 100000/ per annum). A secondary objective was to compare the visual outcomes...
Non-arteritic anterior ischaemic optic neuropathy (NA-AION): a review
1 February 2017
| James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
Ischaemic optic neuropathy (ION) is the commonest adult optic neuropathy encountered today in our ageing population, is a common cause of irreversible visual loss and is usually associated with underlying vascular disease. The condition is classified as follows: (a) Anterior...
Moorfields medical retina consent pathways course
28 February 2025
This brand new, unique MR Pathways consent course is specially designed for nurses, optometrists, doctors and others healthcare professional groups working in medical retina subspeciality in ophthalmology. The MR Pathway consent course enables the multi professional groups to embed the...
Complications after cataract surgery in high myopes: a systematic review and meta-analysis
The authors review all the modern literature on complications after phacoemulsification in high myopes with axial lengths (AL) greater than 25.0mm. Twenty-eight studies reporting on 19,586 eyes were included. The corrected distance visual acuity (CDVA) improved from 0.96 ± 0.53...
Real world results of cataract surgery in pseudoexfoliation
In this single-centre retrospective cohort study, the data of pseudoexfoliation (PXF) patients undergoing phacoemulsification cataract surgery from January 2010 to December 2019 was analysed in the National Health Service setting. The study comprised 23,329 eyes of 15,257 patients. Patients with...
Topical nonsteroidal ant-inflammatory drugs (NSAIDs) in patients undergoing cataract surgery
4 February 2021
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Postoperative inflammation, cataract surgery, diclofenac, laser flare meter, nepafenac
Inflammation is a major risk factor for the development of cystoid macular oedema (CMO) after cataract surgery, leading to breakdown of the blood-retina barrier. There is a correlation between severity of CMO and level of postoperative inflammation. Laser flare meter...
